SCHEMBL274983

SCHEMBL274983

NC(=O)C(F)C1CN(C(=O)c2ccc(F)cc2)C=C(C(=O)O)c2[nH]c3ccccc3c21

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 11/20 0.54
ABCB1 P08183 2/20 0.41
ABCG2 Q9UNQ0 2/20 0.41
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
KCNH2 Q12809 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
POLB P06746 1/20 0.36
ESR1 P03372 1/20 0.35
NR3C1 P04150 1/20 0.35
PGR P06401 1/20 0.35
NR3C2 P08235 1/20 0.35
AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL273912 0.88 NR1H4 (0.53) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL274238 0.88 NR1H4 (0.56) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL688528 0.82 NR1H4 (0.76) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL4303367 0.80 NR1H4 (0.64) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL273500 0.75 NR1H4 (0.73) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL29881430 0.75 NR1H4 (0.73) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL28819666 0.73 NR1H4 (0.61) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL688597 0.73 NR1H4 (0.76) NR1H4ABCB1ABCG2
SCHEMBL29880943 0.72 NR1H4 (0.77) NR1H4ABCB1ABCG2ESR1NR3C1
SCHEMBL689187 0.72 NR1H4 (0.77) NR1H4ABCB1ABCG2ESR1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133992-B2 Azepinoindole and pyridoindole derivatives as pharmaceutical agents EXELIXIS, INC. (US) 2012-03-13 US disclosed
EP-1532153-B1 AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS X CEPTOR THERAPEUTICS INC (US) 2012-02-29 EP disclosed